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Abstract 
Background/Aims: Piceatannol, an analog and metabolite of resveratrol, is effective 
against various disorders including malignancy. It is in part effective by triggering suicidal 
death or apoptosis of tumor cells. Cellular mechanisms mediating the proapoptotic effect of 
Piceatannol include mitochondrial depolarization and cytochrome c release. Erythrocytes lack 
mitochondria but may nevertheless enter suicidal death or eryptosis, which is characterized 
by cell shrinkage and cell membrane scrambling with phosphatidylserine translocation to 
the erythrocyte surface. Cellular mechanisms involved in the triggering of eryptosis include 
increase of cytosolic Ca2+ activity ([Ca2+]i), oxidative stress and ceramide formation. The present 
study explored, whether Piceatannol induces eryptosis and, if so, to shed some light on the 
cellular mechanisms involved. Methods: Phosphatidylserine exposure at the cell surface 
was estimated from annexin-V-binding, cell volume from forward scatter, [Ca2+]i from Fluo3-
fluorescence, reactive oxygen species (ROS) formation from 2’,7’-dichlorodihydrofluorescein 
(DCF) diacetate-dependent fluorescence, and ceramide abundance utilizing specific 
antibodies. Hemoglobin concentration in the supernatant was taken as measure of hemolysis. 
Results: A 48 hours exposure of human erythrocytes to Piceatannol (10 - 20 µM) significantly 
increased the percentage of annexin-V-binding cells, significantly decreased forward scatter, 
significantly increased DCFDA-fluorescence, significantly increased ceramide abundance, 
but did not significantly increase Fluo3-fluorescence. Removal of extracellular Ca2+ slightly 
blunted but did not abolish the effect of Piceatannol on annexin-V-binding and forward 
scatter. Piceatannol (20 µM) significantly augmented the increase of annexin-V-binding, 
but significantly blunted the decrease of forward scatter following treatment with the Ca2+ 
ionophore ionomycin. Conclusions: Piceatannol triggers cell shrinkage and phospholipid 
scrambling of the erythrocyte cell membrane, an effect at least in part downstream of Ca2+ 
and involving oxidative stress and ceramide formation.
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IntroductionPiceatannol (3,3′,4,5′-tetrahydroxy-trans-stilbene), a naturally occurring hydroxylated 
analogue of resveratrol found in diverse plants including grapes and passion fruit [1-
3], is effective against diverse disorders including hypercholesterolemia, arrhythmia, 
atherosclerosis and malignancy [1-3]. Piceatannol fosters vasodilation, counteracts 
angiogenesis as well as oxidative stress [2] and displays anti-inflammatory as well as anti-
microbial activities [1]. Cellular mechanisms triggered by piceatannol include inhibition 
of cyclooxygenase activity [2], cell-cycle arrest [1]; upregulation of Bid, Bax, Bik, Bok, Fas 
as well as P21(WAF1) [1], down-regulation of Bcl-xL as well as BCL-2 [1], mitochondrial 
depolarization [1], cytochrome c release [1], and caspase activation [1]. Piceatannol modifies 
gene expression by downregulation of transcription factor NF-kB [1] and Janus kinase JAK1 
[1]. Depending on the cell type piceatannol may either stimulate [1, 4] or inhibit [1] apoptosis.
In analogy to apoptosis of nucleated cells erythrocytes may enter eryptosis [5], the 
suicidal erythrocyte death characterized by cell shrinkage [6] and cell membrane scrambling 
with phosphatidylserine translocation to the cell surface [5]. Stimulators of eryptosis include 
increase of cytosolic Ca2+ activity ([Ca2+]i) [5], ceramide [7], oxidative stress [5], energy 
depletion [5], activated caspases [5, 8, 9], stimulated activity of casein kinase 1α, Janus-
activated kinase JAK3, protein kinase C, and p38 kinase [5], as well as impaired activity 
of AMP activated kinase AMPK, cGMP-dependent protein kinase, and sorafenib/sunitinib 
sensitive kinases [5]. Eryptosis could be stimulated by a wide variety of xenobiotics [5, 10-
51].
In order to test whether eryptosis could be modified by Piceatannol, human erythrocytes 
drawn from healthy volunteers were exposed to Piceatannol and phosphatidylserine surface 
abundance, cell volume, [Ca2+]i, ROS formation, and ceramide abundance determined by flow 
cytometry. 
Materials and Methods 
Erythrocytes, solutions and chemicals
Fresh Li-Heparin-anticoagulated blood samples were kindly provided by the blood bank of the University 
of Tübingen. The study is approved by the ethics committee of the University of Tübingen (184/2003 V). The 
blood was centrifuged at 120 g for 20 min at 21 °C and the platelets and leukocytes-containing supernatant 
was disposed. Erythrocytes were incubated in vitro at a hematocrit of 0.4% in Ringer solution containing (in 
mM) 125 NaCl, 5 KCl, 1 MgSO
4
, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES; pH 7.4), 5 
glucose, 1 CaCl
2
, at 37°C for 48 hours. Where indicated, erythrocytes were exposed for 48 hours to Piceatannol 
(MedChem Express, Princeton, USA). In order to estimate the impact of Piceatannol on eryptosis due to high 
[Ca2+]i, erythrocytes were exposed for 30 min to a combination of Piceatannol and the Ca2+ ionophore ionomycin 
(Merck Millipore, Darmstadt, Germany).
FACS Analysis of Annexin-V-binding and forward scatter 
After incubation under the respective experimental condition, a 100 µl cell suspension was washed in 
Ringer solution containing 5 mM CaCl
2
 and then stained with Annexin-V-FITC (1:200 dilution; ImmunoTools, 
Friesoythe, Germany) in this solution at 37°C for 20 min under protection from light. The annexin-V-
abundance at the erythrocyte surface was subsequently determined on a FACS Calibur (BD, Heidelberg, 
Germany). Annexin-V-binding was measured with an excitation wavelength of 488 nm and an emission 
wavelength of 530 nm. A marker (M1) was placed to set an arbitrary threshold between annexin-V-binding 
cells and control cells. The same threshold was used for untreated and Piceatannol treated erythrocytes. 
Measurement of Intracellular Ca2+
After incubation, erythrocytes were washed in Ringer solution and loaded with Fluo-3/AM (Biotium, 
Hayward, USA) in Ringer solution containing 5 µM Fluo-3/AM. The cells were incubated at 37°C for 30 
min. Ca2+-dependent fluorescence intensity was measured with an excitation wavelength of 488 nm and an 
emission wavelength of 530 nm on a FACS Calibur.
D
ow
nl
oa
de
d 
by
: 
15
9.
14
9.
55
.1
48
 - 
6/
1/
20
16
 3
:1
8:
31
 P
M
Cell Physiol Biochem 2016;38:2300-2310
DOI: 10.1159/000445584
Published online: May 23, 2016 2302
Signoretto/Castagna/Lang: Piceatannol-Induced Eryptosis 
Cellular Physiology 
and Biochemistry
© 2016 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
Quantification of Reactive oxidant species (ROS) 
Oxidative stress was determined utilizing 2’,7’-dichlorodihydrofluorescein (DCF) diacetate. After 
incubation, a 100 µl suspension of erythrocytes was washed in Ringer solution and stained with DCF 
diacetate (Sigma, Schnelldorf, Germany) in Ringer solution containing DCFDA at a final concentration 
of 10 µM. Erythrocytes were incubated at 37°C for 30 min in the dark and washed two times in Ringer 
solution. The DCFDA-loaded erythrocytes were resuspended in 200 µl Ringer solution and ROS-dependent 
fluorescence intensity was measured at an excitation wavelength of 488 nm and an emission wavelength of 
530 nm on a FACS Calibur (BD).
Determination of Ceramide formation
To determine ceramide abundance, a monoclonal antibody-based assay was used. To this end, cells were 
stained for 1 hour at 37°C with 1 µg/ml anti ceramide antibody (clone MID 15B4, Alexis, Grünberg, Germany) 
in PBS containing 0.1% bovine serum albumin (BSA) at a dilution of 1:10. The samples were washed twice 
with PBS-BSA. The cells were stained for 30 minutes with polyclonal fluorescein isothiocyanate (FITC) 
conjugated goat anti-mouse IgG and IgM specific antibody (Pharmingen, Hamburg, Germany) diluted 1:50 in 
PBS-BSA. Unbound secondary antibody was removed by repeated washing with PBS-BSA. The samples were 
analyzed by flow cytometric analysis with an excitation wavelength of 488 nm and an emission wavelength 
of 530 nm. As a control, secondary antibody alone was used.
Hemolysis
For the determination of hemolysis, the samples were centrifuged (10 min at 2000 rpm, room 
temperature) after incubation, and the supernatants were harvested. As a measure of hemolysis, the 
hemoglobin (Hb) concentration of the supernatant was determined photometrically at 405 nm. The 
absorption of the supernatant of erythrocytes lysed in distilled water was defined as 100% hemolysis.
Statistics
Data are expressed as arithmetic means ± SEM. As indicated in the figure legends, statistical analysis 
was made using ANOVA with Tukey’s test as post-test and t test as appropriate. n denotes the number of 
different erythrocyte specimens studied. Since different erythrocyte specimens used in distinct experiments 
are differently susceptible to triggers of eryptosis, the same erythrocyte specimens have been used for control 
and experimental conditions.
Results
The present study explored whether Piceatannol stimulates eryptosis, the suicidal 
erythrocyte death characterized by cell shrinkage and phospholipid scrambling of the cell 
membrane with phosphatidylserine translocation to the cell surface. 
Erythrocyte volume was estimated from forward scatter which was determined utilizing 
flow cytometry. The measurements were performed after incubation of the erythrocytes 48 
hours in Ringer solution without or with Piceatannol (5 – 20 µM). As shown in Fig. 1A, B, 
Piceatannol slightly decreased the average erythrocyte forward scatter, an effect reaching 
statistical significance at 20 µM Piceatannol. Fig. 1C, D demonstrates that Piceatannol 
significantly increased the percentage of both severely swollen and severely shrunken 
erythrocytes. 
Phosphatidylserine exposing erythrocytes were identified utilizing annexin-V-binding, 
as determined by flow cytometry. Prior to measurements, the erythrocytes were again 
incubated for 48 hours in Ringer solution without or with Piceatannol (5 – 20 µM). As shown 
in Fig. 2, a 48 hours exposure to Piceatannol increased the percentage of phosphatidylserine 
exposing erythrocytes, an effect reaching statistical significance at 10 µM Piceatannol. For 
comparison, the percentage of hemolysis after 48 hours exposure in Ringer solution without 
or with Piceatannol (5 – 20 µM) is shown in the same bar chart (Fig. 2B; grey bars).
Fluo3-fluorescence was taken as a measure of cytosolic Ca2+ activity ([Ca2+]i). As a 
result, the average Fluo3-fluorescence was similar following a 48 hours incubation without 
Piceatannol as in the presence of Piceatannol (5 - 20 µM) (Table 1).
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A next series of experiments explored whether the Piceatannol-induced translocation 
of phosphatidylserine or erythrocyte shrinkage required entry of extracellular Ca2+. To 
this end, erythrocytes were incubated for 48 hours in the absence or presence of 20 µM 
Piceatannol in the presence or nominal absence of extracellular Ca2+. As illustrated in Fig. 3, 
removal of extracellular Ca2+ slightly, but significantly blunted the effect of Piceatannol on 
Fig. 1. Effect of Piceatan-
nol on erythrocyte forward 
scatter. A. Original histo-
gram of forward scatter 
of erythrocytes following 
exposure for 48 hours to 
Ringer solution without 
(grey area) and with (black 
line) presence of 20 µM 
Piceatannol. B. Arithmetic 
means ± SEM (n = 10) of 
the erythrocyte forward 
scatter (FSC) following in-
cubation for 48 hours to 
Ringer solution without 
(white bar) or with (black 
bars) Piceatannol (5 - 20 
µM). C. Arithmetic means 
± SEM (n = 10) of the per-
centage erythrocytes with 
forward scatter (FSC) <200 
Fig. 2. Effect of Piceatan-
nol on phosphatidylser-
ine exposure and hemoly-
sis. A. Original histogram 
of annexin-V-binding of 
erythrocytes following 
exposure for 48 hours 
to Ringer solution with-
out (grey area) and with 
(black line) presence 
of 20 µM Piceatannol. 
Table 1. Fluo3-fluorescence following incubation for 48 hours without or with 
Piceatannol treatment
following incubation for 48 hours to Ringer solution without (white bar) or with (black bars) Piceatan-
nol (5 – 20 µM). D. Arithmetic means ± SEM (n = 10) of the percentage erythrocytes with forward scat-
ter (FSC) >800 following incubation for 48 hours to Ringer solution without (white bar) or with (black 
bars) Piceatannol (5 – 20 µM). **(p<0.01), ***(p<0.001) indicates significant difference from the absence of 
Piceatannol (ANOVA).
B. Arithmetic means ± SEM (n = 10) of erythrocyte annexin-V-binding following incubation for 48 hours to 
Ringer solution without (white bar) or with (black bars) Piceatannol (5 - 20 µM). For comparison, arith-
metic means ± SEM (n = 10) of the percentage of hemolysis is shown as grey bars. ***(p<0.001) indicates 
significant difference from the absence of Piceatannol (ANOVA).
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forward scatter. However, even in the absence of extracellular Ca2+, Piceatannol significantly 
decreased the erythrocyte forward scatter. Similar observations were made with annexin-
V-binding. Removal of extracellular Ca2+ slightly, but significantly blunted the effect of 
Piceatannol on annexin-V-binding. However, even in the absence of extracellular Ca2+, 
Piceatannol significantly increased the percentage of annexin-V-binding erythrocytes (Fig. 
3). Thus, Piceatannol-induced cell membrane scrambling was in large part triggered by 
mechanisms insensitive to entry of extracellular Ca2+.
A next series of experiments explored whether Piceatannol modified cell shrinkage and 
translocation of phosphatidylserine following increase of cytosolic Ca2+ activity by treatment 
of the erythrocytes with Ca2+ ionophore ionomycin (1 µM). To this end, erythrocytes were 
incubated for 48 hours in the absence or presence of 20 µM Piceatannol and subsequently 
treated for 30 minutes with ionomycin (1 µM). As illustrated in Fig. 4A following Piceatannol 
pretreatment, ionomycin increased cytosolic Ca2+ activity to similar values in erythrocytes 
with or without Piceatannol treatment. However, the effect of ionomycin on forward 
scatter was significantly blunted (Fig. 4C) and the effect of ionomycin on annexin-V-binding 
significantly stronger following Piceatannol pretreatment (Fig. 4B). 
Fig. 3. Ca2+ sensitivity of Piceatannol -induced erythrocyte shrinkage and phosphatidylserine exposure. 
A,B. Original histogram of forward scatter of erythrocytes following exposure for 48 hours to Ringer solu-
tion without (grey area) and with (black line) Piceatannol (20 µM) in the presence (A) and absence (B) of 
extracellular Ca2+. C. Arithmetic means ± SEM (n = 10) of forward scatter of erythrocytes after a 48 hours 
treatment with Ringer solution without (white bars) or with (black bars) Piceatannol (20 µM) in the pres-
ence (left bars, +Ca2+) and absence (right bars, -Ca2+) of Ca2+. D,E. Original histogram of annexin-V-binding 
of erythrocytes following exposure for 48 hours to Ringer solution without (grey area) and with (black 
line) Piceatannol (20 µM) in the presence (D) and absence (F) of extracellular Ca2+. F. Arithmetic means ± 
SEM (n = 10) of annexin-V-binding of erythrocytes after a 48 hours treatment with Ringer solution without 
(white bars) or with (black bars) Piceatannol (20 µM) in the presence (left bars, +Ca2+) and absence (right 
bars, -Ca2+) of Ca2+. *(p<0.05),***(p<0.001) indicates significant difference from the absence of Piceatannol, 
#(p<0.05), ##(p<0.01) indicates significant difference from the nominal absence of Ca2+ (ANOVA).
D
ow
nl
oa
de
d 
by
: 
15
9.
14
9.
55
.1
48
 - 
6/
1/
20
16
 3
:1
8:
31
 P
M
Cell Physiol Biochem 2016;38:2300-2310
DOI: 10.1159/000445584
Published online: May 23, 2016 2305
Signoretto/Castagna/Lang: Piceatannol-Induced Eryptosis 
Cellular Physiology 
and Biochemistry
© 2016 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
Eryptosis is further stimulated by oxidative stress. Reactive oxygen species (ROS) was 
thus quantified utilizing 2′,7′-dichlorodihydrofluorescein (DCF) diacetate. As indicated in 
Fig. 5, the DCFDA-fluorescence was higher following exposure to Piceatannol than in the 
absence of Piceatannol, a difference reaching statistical significance at 10 µM Piceatannol 
concentration.
A further stimulator of eryptosis is ceramide. Ceramide abundance at the erythrocyte 
surface was thus quantified utilizing specific antibodies. As shown in Fig. 6, the ceramide 
abundance was significantly higher following exposure to 20 µM Piceatannol than in the 
absence of Piceatannol.
Discussion
The present observations reveal that exposure of human erythrocytes drawn from 
healthy individuals to the 3,3′,4,5′-tetrahydroxy-trans-stilbene (Piceatannol) is followed by 
cell shrinkage and cell membrane scrambling with phosphatidylserine translocation to the 
erythrocyte surface. Thus, Piceatannol stimulates the suicidal erythrocyte death or eryptosis.
Fig. 4. Effect of Ca2+ ionophore ionomycin on phosphatidylserine exposure in the presence and absence 
of Piceatannol. A-C. Arithmetic means ± SEM (n = 10) of (A) the Fluo3-fluorescence, (B) the percentage of 
annexin-V-binding erythrocytes, and (C) the forward scatter following incubation for 30 min in the absence 
(left bars, -ionomycin) or presence (right bars, +ionomycin) of Ca2+ ionophore ionomycin (1 µM) after a 48 
hours preincubation in the absence (white bars) or presence (black bars) of 20 µM Piceatannol. *(p<0.05), 
***(p<0.001) indicates significant difference from the absence of Piceatannol. ###(p<0.001) indicates 
significant difference from the absence of ionomycin (ANOVA).
Fig. 5. Effect of Piceatannol on erythrocyte ROS formation. A. Original histogram of DCFDA-fluorescence 
in erythrocytes following exposure for 48 hours to Ringer solution without (grey area) and with (black 
line) presence of Piceatannol (20 µM). B. Arithmetic means ± SEM (n = 10) of the DCFDA-fluorescence 
(arbitrary units) in erythrocytes exposed for 48 hours to Ringer solution without (white bar) or with (black 
bars) Piceatannol (5– 20 µM). *(p<0.05), ***(p<0.001) indicate significant difference from the absence of 
Piceatannol (ANOVA).
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The experiments further shed some light on the cellular mechanisms involved. Piceatannol 
did not appreciably increase cytosolic Ca2+ activity ([Ca2+]i). Instead, it slightly tended to 
decrease Fluo-3AM fluorescence, an effect, however, not reaching statistical significance. We 
cannot rule out an artifact, such as cellular loss of fluorescent dye. Nevertheless, the effect 
of Piceatannol on cell membrane scrambling was slightly, but significantly blunted following 
removal of extracellular Ca2+. However, Piceatannol increased the percentage of annexin-V-
binding erythrocytes even in the absence of extracellular Ca2+. Moreover, Piceatannol augmented 
cell membrane scrambling in erythrocytes loaded with Ca2+ by treatment with the Ca2+ ionophore 
ionomycin. Thus, Piceatannol apparently sensitized the cells to the scrambling effect of Ca2+ and 
was effective downstream of Ca2+. The sensitivity of cell membrane scrambling to Ca2+ could 
be enhanced by ceramide [5]. Piceatannol indeed enhanced the ceramide abundance, which 
could well contribute to or even account for the sensitization of cell membrane scrambling to 
[Ca2+]i. Moreover, the stimulation of cell membrane scrambling by Piceatannol was paralleled by 
oxidative stress, a major stimulator of eryptosis [5].
The effect of Piceatannol on cell shrinkage was again slightly, but significantly blunted by 
removal of Ca2+ from the extracellular space. On the other hand, Piceatannol significantly blunted 
the effect of the Ca2+ ionophore ionomycin on cell shrinkage. Ionomycin triggers cell shrinkage by 
increase of [Ca2+]i with subsequent activation of Ca2+ sensitive K+ channels, K+ exit, cell membrane 
hyperpolarization, Cl- exit and thus cellular loss of KCl with water. Possibly, preincubation to 
Piceatannol was followed by impairment of Na+/K+ ATPase with gain of cytosolic Na+ and loss 
of cellular K+. As a result, the K+ exit, hyperpolarisation and Cl- loss following opening of Ca2+ 
sensitive K+ channels would be blunted by prior treatment with Piceatannol. 
At low concentrations Piceatannol decreases and at high concentrations Piceatannol 
increases hemolysis and thus release of hemoglobin. Hemoglobin released into circulating 
blood may pass the renal glomerular filter, precipitate in the acidic lumen of renal tubules, 
occlude nephrons and thus lead to renal failure [52]. An important function of eryptosis is 
the disposal of defective erythrocytes prior to hemolysis. Eryptosis further accomplishes 
elimination of erythrocytes infected with the malaria pathogen Plasmodium [5]. 
Excessive eryptosis may, however, result in anemia, if the loss of eryptotic erythrocytes 
outcasts the formation of new erythrocytes by erythropoiesis [5]. Phosphatidylserine 
exposing erythrocytes further adhere to the vascular wall [53], stimulate blood clotting 
and trigger thrombosis [54-56], thus impairing microcirculation [7, 54, 57-60]. Enhanced 
eryptosis may thus contribute to the anemia and/or deranged microcirculation in several 
clinical conditions, such as chronic dehydration [61], hyperphosphatemia [62], chronic 
kidney disease (CKD) [63-66], hemolytic-uremic syndrome [67], diabetes [68], hepatic 
Fig. 6. Effect of Piceatannol on ceramide abundance at the erythrocyte surface. A. Original histogram of 
ceramide abundance in erythrocytes following exposure for 48 hours to Ringer solution without (grey area) 
and with (black line) presence of 20 µM Piceatannol. B. Arithmetic means ± SEM (n = 10) of the ceramide 
abundance (arbitrary units) in erythrocytes exposed for 48 hours to Ringer solution without (white bar) 
or with (black bar) presence of 20 µM Piceatannol. ***(p<0.001) indicates significant difference from the 
absence of Piceatannol (ANOVA).
D
ow
nl
oa
de
d 
by
: 
15
9.
14
9.
55
.1
48
 - 
6/
1/
20
16
 3
:1
8:
31
 P
M
Cell Physiol Biochem 2016;38:2300-2310
DOI: 10.1159/000445584
Published online: May 23, 2016 2307
Signoretto/Castagna/Lang: Piceatannol-Induced Eryptosis 
Cellular Physiology 
and Biochemistry
© 2016 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
failure [69], malignancy [5], sepsis [70], sickle-cell disease [5], beta-thalassemia [5], Hb-C 
and G6PD-deficiency [5], as well as Wilsons disease [71]. At least in theory, treatment of 
affected patients with Piceatannol may further aggravate anemia. 
The effect of Piceatannol contrasts that of the related substance resveratrol [72-74], which 
has been shown to inhibit eryptosis [75]. 
In conclusion, Piceatannol triggers eryptosis with cell shrinkage and cell membrane 
scrambling, an effect apparently independent from Ca2+ entry, but involving oxidative stress and 
ceramide.  
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